Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

Objectives. TEACH (NCT00896051) was a randomized, open-label, two-arm Phase II trial to investigate the pharmacokinetic interaction between etravirine and atazanavir/ritonavir and safety and efficacy in treatment-experienced, HIV-1-infected patients. Methods. After a two-week lead-in of two nucleosi...

全面介紹

Na minha lista:
書目詳細資料
發表在:AIDS Res Treat
Main Authors: Orrell, Catherine, Felizarta, Franco, Nell, André, Kakuda, Thomas N., Lavreys, Ludo, Nijs, Steven, Tambuyzer, Lotke, Van Solingen-Ristea, Rodica, Tomaka, Frank L.
格式: Artigo
語言:Inglês
出版: Hindawi Publishing Corporation 2015
主題:
Clinical Study
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4312629/
https://ncbi.nlm.nih.gov/pubmed/25664185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/938628
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍